CHCL Stock View

Cian Healthcare Ltd

CHCL Stock View

(BSE)

Trade

0.41 | 1.78

Market Cap ₹( Cr.)
574.15

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
24-Sep-2023

 

Copy Link

Cian Healthcare Limited is an India-based company. The Company is engaged in the manufacturing and marketing of pharmaceutical products. It renders services for Third Party Pharmaceutical Manufacturing. The Company is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. It is also engaged in the business of manufacturing cosmetic products. The Company caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data